These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1886930)

  • 21. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
    Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
    Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experiences in the treatment of malignant melanoma of the choroid with 106Ru-106Rh beta-ray applicators.
    Lommatzsch PK
    Trans Ophthalmol Soc U K (1962); 1973; 93(0):119-32. PubMed ID: 4526435
    [No Abstract]   [Full Text] [Related]  

  • 23. Results of contact beta-irradiation of choroidal melanomas.
    Damjanovich J; Berta A; Vezendi L
    Acta Chir Hung; 1997; 36(1-4):67-8. PubMed ID: 9408291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choroidal melanoma metastatic to the contralateral choroid.
    Singh AD; Shields JA; Shields CL; Sato T
    Am J Ophthalmol; 2001 Dec; 132(6):941-3. PubMed ID: 11730671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The design and the dosimetry of bi-nuclide radioactive ophthalmic applicators.
    Flühs D; Anastassiou G; Wening J; Sauerwein W; Bornfeld N
    Med Phys; 2004 Jun; 31(6):1481-8. PubMed ID: 15259651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geographic atrophy and choroidal melanoma located 3 mm apart.
    Geirsdottir A; Hungerford J; Stefansson E; Jonasson F; Helgadottir G; Sigurdsson H
    Acta Ophthalmol; 2008 Aug; 86(5):584-5. PubMed ID: 18221498
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators.
    Lommatzsch PK
    Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):428-9. PubMed ID: 274003
    [No Abstract]   [Full Text] [Related]  

  • 28. [Radiation retinopathy following treatment of choroid melanomas with 106Ru/106Rh applicators].
    Foerster MH; Fried M; Wessing A; Meyer-Schwickerath G
    Fortschr Ophthalmol; 1983; 80(5):418-21. PubMed ID: 6642368
    [No Abstract]   [Full Text] [Related]  

  • 29. Irido-cilio-choroidal melanoma in a 5-year-old boy treated by Ru-106 brachytherapy.
    Pe'er J; Averbukh E; Frenkel S
    Clin Exp Ophthalmol; 2009 Sep; 37(7):742-3. PubMed ID: 19788674
    [No Abstract]   [Full Text] [Related]  

  • 30. Choroidal melanoma suspect. Conservative treatment and evolution. Case report.
    Zemba M; Malciolu RA
    Rom J Ophthalmol; 2016; 60(4):264-269. PubMed ID: 29450360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Choroidal metastasis of cutaneous malignant melanoma treated by ruthenium-106 plaque irradiation.
    Anteby I; Axer-Siegel R; Pe'er J
    Ann Ophthalmol; 1993 Sep; 25(9):339-41. PubMed ID: 8297070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Complications of the irradiation therapy with beta applicators in malign melanomas (author's transl)].
    Hallermann D
    Klin Monbl Augenheilkd; 1979 Jun; 174(6):982-4. PubMed ID: 480853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Techniques and results of 106Ru/106Rh radiation of choroidal tumours.
    Busse H; Müller RP
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 1)():72-7. PubMed ID: 6581639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A procedure for the determination of dose performance of radioactive eye applicators (106-Ru/106-Rh) and their significance for indications and treatment in malignant choroid melanomas].
    Menapace R; Binder W
    Klin Monbl Augenheilkd; 1985 Nov; 187(5):451-4. PubMed ID: 4087812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
    Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
    Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible effects of radiobiological parameters on metastatic spread of uveal melanomas treated with 106Ru plaques.
    Kleineidam M; Guthoff R
    Ger J Ophthalmol; 1994 Jan; 3(1):22-5; discussion 25-6. PubMed ID: 8142877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric comparison of 106Ru and 125I plaques for treatment of shallow (Wilkinson DA; Kolar M; Fleming PA; Singh AD
    Br J Radiol; 2008 Oct; 81(970):784-9. PubMed ID: 18628320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.
    Papageorgiou KI; Cohen VM; Bunce C; Kinsella M; Hungerford JL
    Br J Ophthalmol; 2011 Feb; 95(2):166-70. PubMed ID: 20889528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does choroidal melanoma regression correlate with chromosome 3 loss after ruthenium brachytherapy?
    Chiam PJ; Coupland SE; Kalirai H; Groenewald C; Heimann H; Damato BE
    Br J Ophthalmol; 2014 Jul; 98(7):967-71. PubMed ID: 24518077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Optimizing target volume assessment in irradiation of intraocular melanomas with ruthenium applicators].
    Poier E; Langmann G; Leitner H; Vidic B
    Fortschr Ophthalmol; 1991; 88(2):158-60. PubMed ID: 1855736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.